Literature DB >> 12117936

Fimbriated Salmonella enterica serovar typhimurium abates initial inflammatory responses by macrophages.

David W Pascual1, Theresa Trunkle, Jamie Sura.   

Abstract

Oral immunization of mice with a Salmonella vaccine expressing colonization factor antigen I (CFA/I) from enterotoxigenic Escherichia coli results in the rapid onset of interleukin-4 (IL-4) and IL-5 production, which explains the observed elevations in mucosal immunoglobulin A (IgA) and serum IgG1 antibodies. In contrast, oral immunization with the Salmonella vector does not result in the production of Th2-type cytokines. To begin to assess why such differences exist between the two strains, it should be noted that in vitro infection of RAW 264.7 macrophages resulted in the absence of nitric oxide (NO) production in cells infected with the Salmonella-CFA/I vaccine. This observation suggests differential proinflammatory cytokine production by these isogenic Salmonella strains. Upon measurement of proinflammatory cytokines, minimal to no tumor necrosis factor alpha (TNF-alpha), IL-1alpha, IL-1beta, or IL-6 was produced by Salmonella-CFA/I-infected RAW 264.7 or peritoneal macrophages, but production was greatly induced in Salmonella vector-infected macrophages. Only minute levels of IL-12 p70 were induced by Salmonella vector-infected macrophages, and none was induced by Salmonella-CFA/I-infected macrophages. The absence of IL-12 was not due to overt increases in production of either IL-12 p40 or IL-10. CFU measurements taken at 8 h postinfection showed no differences in colonization in RAW 264.7 cells infected with either Salmonella construct, but there were differences in peritoneal macrophages. However, after 24 h, the Salmonella vector strain colonized to a greater extent in RAW 264.7 cells than in peritoneal macrophages. Infection of RAW 264.7 cells or peritoneal macrophages with either Salmonella construct showed no difference in macrophage viabilities. This evidence shows that the expression of CFA/I fimbriae alters how macrophages recognize or process salmonellae and prevents the rapid onset of proinflammatory cytokines which is typical during Salmonella infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117936      PMCID: PMC128151          DOI: 10.1128/IAI.70.8.4273-4281.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G Yap; M Pesin; A Sher
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.

Authors:  D W Pascual; M D White; T Larson; N Walters
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

4.  Salmonella infection does not increase expression and activity of the high affinity IL-12 receptor.

Authors:  A Elhofy; I Marriott; K L Bost
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 5.  Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions.

Authors:  J R Forbes; P Gros
Journal:  Trends Microbiol       Date:  2001-08       Impact factor: 17.079

6.  Salmonella DNA adenine methylase mutants elicit protective immune responses to homologous and heterologous serovars in chickens.

Authors:  E L Dueger; J K House; D M Heithoff; M J Mahan
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/- mice.

Authors:  G P Ables; D Takamatsu; H Noma; S El-Shazly; H K Jin; T Taniguchi; K Sekikawa; T Watanabe
Journal:  J Interferon Cytokine Res       Date:  2001-01       Impact factor: 2.607

8.  Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection.

Authors:  S K Bliss; B A Butcher; E Y Denkers
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

9.  Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies.

Authors:  P Mastroeni; A Arena; G B Costa; M C Liberto; L Bonina; C E Hormaeche
Journal:  Microb Pathog       Date:  1991-07       Impact factor: 3.738

10.  Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane.

Authors:  N Jabado; A Jankowski; S Dougaparsad; V Picard; S Grinstein; P Gros
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  24 in total

1.  Coming of AGE: facile generation of attenuated vaccine strains through heterologous gene expression.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

2.  Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.

Authors:  Xinghong Yang; Zhiyong Suo; Theresa Thornburg; Kathryn Holderness; Ling Cao; Timothy Lim; Nancy Walters; Laura Kellerman; Linda Loetterle; Recep Avci; David W Pascual
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

3.  Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.

Authors:  Nancy Walters; Theresa Trunkle; Michael Sura; David W Pascual
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge.

Authors:  Xinghong Yang; Todd Becker; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Efficient immobilization and patterning of live bacterial cells.

Authors:  Zhiyong Suo; Recep Avci; Xinghong Yang; David W Pascual
Journal:  Langmuir       Date:  2008-03-06       Impact factor: 3.882

6.  A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Sarah Golden; Catharine M Bosio; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

7.  Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.

Authors:  Irina Kochetkova; Theresa Thornburg; Gayle Callis; Kathryn Holderness; Massimo Maddaloni; David W Pascual
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

8.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

9.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

10.  Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.

Authors:  Sung Jae Shin; Seung Won Shin; Mi Lan Kang; Deog Yong Lee; Moon-Sik Yang; Yong-Suk Jang; Han Sang Yoo
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.